These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24329999)

  • 41. Determination of the longest intrapatient left ventricular electrical delay may predict acute hemodynamic improvement in patients after cardiac resynchronization therapy.
    Zanon F; Baracca E; Pastore G; Fraccaro C; Roncon L; Aggio S; Noventa F; Mazza A; Prinzen F
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):377-83. PubMed ID: 24668162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Performance of a novel left ventricular lead with short bipolar spacing for cardiac resynchronization therapy: primary results of the Attain Performa quadripolar left ventricular lead study.
    Crossley GH; Biffi M; Johnson B; Lin A; Gras D; Hussin A; Cuffio A; Collier JL; El-Chami M; Li S; Holloman K; Exner DV
    Heart Rhythm; 2015 Apr; 12(4):751-8. PubMed ID: 25533587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of left ventricular electrical delay on the acute hemodynamic response with cardiac resynchronization therapy.
    Gold MR; Leman RB; Wold N; Sturdivant JL; Yu Y
    J Cardiovasc Electrophysiol; 2014 Jun; 25(6):624-30. PubMed ID: 24446891
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiac resynchronization therapy reduces T-wave alternans in patients with heart failure.
    Hua W; Chen K; Zhou X; Dai Y; Chen R; Wang J; Ding L; Liu Z; Feng T; Yu J; Cheng J; Liu C; Zhang S
    Europace; 2015 Feb; 17(2):281-8. PubMed ID: 25398405
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bipolar active fixation left ventricular lead or quadripolar passive fixation lead? An Italian multicenter experience.
    Ziacchi M; Giannola G; Lunati M; Infusino T; Luzzi G; Rordorf R; Pecora D; Bongiorni MG; De Ruvo E; Biffi M
    J Cardiovasc Med (Hagerstown); 2019 Apr; 20(4):192-200. PubMed ID: 30762662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy.
    Barra S; Looi KL; Gajendragadkar PR; Khan FZ; Virdee M; Agarwal S
    Europace; 2016 Aug; 18(8):1187-93. PubMed ID: 26566940
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Model-based navigation of left and right ventricular leads to optimal targets for cardiac resynchronization therapy: a single-center feasibility study.
    Laksman Z; Yee R; Stirrat J; Gula LJ; Skanes AC; Leong-Sit P; Manlucu J; McCarty D; Turkistani Y; Scholl D; Rajchl M; Goela A; Islam A; Thompson RT; Drangova M; White JA
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1040-7. PubMed ID: 25221334
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only.
    Palmisano P; Accogli M; Pisanò EC; Zaccaria M; De Blasi S; Ponzetta MA; Valsecchi S; Milanese G; Lauretti M; Magliari F
    Europace; 2016 Sep; 18(9):1374-82. PubMed ID: 26612878
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An individualized left ventricular lead-targeting strategy improves long-term survival of cardiac resynchronization therapy patients and influences the benefit of the implantable cardioverter-defibrillator: a long-term follow-up of the TARGET study.
    Barra S; Yu E; Khan F; Dutka D; Virdee M
    J Cardiovasc Med (Hagerstown); 2017 Jul; 18(7):553-555. PubMed ID: 27136703
    [No Abstract]   [Full Text] [Related]  

  • 50. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
    Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ;
    Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of Smaller Left Ventricular Capture Threshold Safety Margins to Improve Device Longevity in Recipients of Cardiac Resynchronization-Defibrillation Therapy.
    Steinhaus DA; Waks JW; Collins R; Kleckner K; Kramer DB; Zimetbaum PJ
    Am J Cardiol; 2015 Jul; 116(1):85-7. PubMed ID: 25933732
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bifocal left ventricular stimulation or the optimal left ventricular stimulation site in cardiac resynchronization therapy: a pressure-volume loop study.
    de Roest GJ; Wu L; de Cock CC; Delnoy PP; Hendriks ML; van Rossum AC; Allaart CP
    Europace; 2016 Jul; 18(7):1030-7. PubMed ID: 26498161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term follow-up of patients with a quadripolar active fixation left ventricular lead: An Italian multicenter experience.
    De Regibus V; Biffi M; Infusino T; Savastano S; Landolina M; Palmisano P; Foti R; Facchin D; Dello Russo A; Urraro F; Ziacchi M
    J Cardiovasc Electrophysiol; 2022 Jul; 33(7):1567-1575. PubMed ID: 35634866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex ≥120 milliseconds.
    Thibault B; Ducharme A; Harel F; White M; O'Meara E; Guertin MC; Lavoie J; Frasure-Smith N; Dubuc M; Guerra P; Macle L; Rivard L; Roy D; Talajic M; Khairy P;
    Circulation; 2011 Dec; 124(25):2874-81. PubMed ID: 22104549
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anodal right ventricular capture during left ventricular stimulation in CRT-implantable cardioverter defibrillators.
    Thibault B; Roy D; Guerra PG; Macle L; Dubuc M; Gagné P; Greiss I; Novak P; Furlani A; Talajic M
    Pacing Clin Electrophysiol; 2005 Jul; 28(7):613-9. PubMed ID: 16008795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators.
    Alam MB; Munir MB; Rattan R; Flanigan S; Adelstein E; Jain S; Saba S
    Europace; 2014 Feb; 16(2):246-51. PubMed ID: 24099864
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Super-response to cardiac resynchronization therapy may predict late phrenic nerve stimulation.
    Juliá J; López-Gil M; Fontenla A; Lozano Á; Villagraz L; Salguero R; Arribas F
    Europace; 2018 Sep; 20(9):1498-1505. PubMed ID: 29182757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of pacing site on QRS duration and its relationship to hemodynamic response in cardiac resynchronization therapy for congestive heart failure.
    Derval N; Bordachar P; Lim HS; Sacher F; Ploux S; Laborderie J; Steendijk P; Deplagne A; Ritter P; Garrigue S; Denis A; Hocini M; Haissaguerre M; Clementy J; Jaïs P
    J Cardiovasc Electrophysiol; 2014 Sep; 25(9):1012-1020. PubMed ID: 24891271
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of phrenic stimulation in CRT patients over the long term: still an unmet need ?
    Biffi M; Bertini M; Ziacchi M; Gardini B; Mazzotti A; Massaro G; Diemberger I; Martignani C; Valzania C; Boriani G
    Pacing Clin Electrophysiol; 2011 Oct; 34(10):1201-8. PubMed ID: 21651592
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.
    Rönn F; Kesek M; Karp K; Henein M; Jensen SM
    Europace; 2011 Dec; 13(12):1747-52. PubMed ID: 21712261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.